Matrix elasticity directs stem cell lineage specification

The landmark Cell paper that demonstrated mesenchymal stem cells choose their lineage by feeling the mechanical stiffness of their extracellular matrix — a finding that consolidated the mechanotransduction field's central claim that cells read their mechanical environment as a determinant of behaviour. Lead author Adam Engler was a graduate student in Dennis Discher's lab at the University of Pennsylvania at the time of the work; Discher is the senior author and one of the principal figures of the post-2000 mechanobiology field. H. Lee Sweeney at Penn contributed the muscle-and-myosin expertise; Shamik Sen was a colleague in the Discher lab.

Published in Cell in August 2006, the paper is a primary empirical report combining polyacrylamide-gel matrices of controlled stiffness with naive mesenchymal stem cell culture. The headline finding: stem cells on soft matrices (mimicking brain, ~1 kPa) become neurogenic; on intermediate-stiffness matrices (mimicking muscle, ~10 kPa) become myogenic; on stiffer matrices (mimicking pre-mineralised bone, ~30 kPa) become osteogenic. The mechanism — non-muscle myosin II — links the cell's contractile machinery to the matrix stiffness it can resist against. Inhibiting myosin II blocks the stiffness-directed lineage choice without substantially affecting other cell functions. The paper has been cited over twelve thousand times.

The piece sits as adjacent to the interstitium literature rather than at its centre. The connection is that the extracellular matrix is part of the interstitial compartment, and the mechanotransduction the paper documents is one of the mechanisms by which interstitial-matrix properties translate into cellular behaviour. The cancer-microenvironment programme ( Heldin, Swartz and Lund) draws on this mechanotransduction framework to explain how elevated interstitial pressure and matrix stiffening alter stromal and tumour cell behaviour. The Cenaj 2021 continuity paper discussion section cites this kind of work as the mechanism by which interstitial-architecture changes could have body-wide cellular consequences.

The stake is scientific and translational. Discher's lab has spun out substantial mechanobiology programme work and has commercial interest in matrix-elasticity-controlled cell-therapy platforms; the paper itself is a careful primary report whose provenance is unimpeachable. Read it for the mechanotransduction foundation that the post-2018 interstitium literature draws on, not as a direct interstitium paper.